Coloplast A/S (0QBO.IL)

846,20 0,00 (0,00%) Alla chiusura: 05:47PM BST

Coloplast A/S

Holtedam 1-3
Humlebæk 3050
Denmark
45 49 11 11 11
https://www.coloplast.com

Settore/i: Healthcare
Settore: Medical Instruments & Supplies
Impiegati a tempo pieno: 14.700

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Kristian Villumsen	Pres & CEO	15,7M	N/D	1970
Mr. Anders Lonning-Skovgaard	Exec. VP & CFO	8M	N/D	1972
Mr. Allan Rasmussen	Exec. VP of Global Operations	7,1M	N/D	1967
Mr. Nicolai Buhl Andersen	Exec. VP of Innovation	6,8M	N/D	1969
Mr. Paul Marcun	Exec. VP of Growth	8,1M	N/D	1967
Mr. Thomas Barfod	Sr. Controller & Employees Representative Director	450k	N/D	1970
Ellen Bjurgert	VP of Investor Relations	N/D	N/D	N/D
Dennis Kaysen	Director of Corp. Communications	N/D	N/D	N/D
Dorthe Ronnau	Sr. VP of People & Culture	N/D	N/D	1966
Mr. Alain Morvan	Sr. VP of Sales Europe	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in DKK.

Descrizione

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Governance aziendale

L'ISS Governance QualityScore di Coloplast A/S al 1 ottobre 2023 è 3. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 4; diritti degli azionisti: 9; retribuzione: 5.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.